These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. Bhatt DL; Kapadia SR; Yadav JS; Topol EJ Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181 [TBL] [Abstract][Full Text] [Related]
3. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents. Jamieson DG; Parekh A; Ezekowitz MD J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203 [TBL] [Abstract][Full Text] [Related]
11. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. Tran H; Anand SS JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275 [TBL] [Abstract][Full Text] [Related]
13. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415 [TBL] [Abstract][Full Text] [Related]
14. Combination antiplatelet agents in ischemic cerebrovascular disease. Moussouttas M; Papamitsakis N Mt Sinai J Med; 2005 Jan; 72(1):16-22. PubMed ID: 15682258 [TBL] [Abstract][Full Text] [Related]
18. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161 [TBL] [Abstract][Full Text] [Related]
19. Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events. Guthrie R Adv Ther; 2011 Jun; 28(6):473-82. PubMed ID: 21547541 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®). Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]